Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Popovic

Showing results (21-30 of 303) with videos related to

Pageof 31
Sort By:
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|November 11, 2023
Potential New Therapeutic Implications of Semaglutide: New Colours of the Rainbow?Evanthia Gouveri, Djordje S Popovic, Nikolaos Papanas
Diabetes Research and Clinical Practice|February 19, 2026
Combination therapy for kidney protection in type 1 diabetes mellitus: quo vadis?Djordje S Popovic, Dimitrios Patoulias, Theocharis Koufakis
Diabetes & Metabolism|February 26, 2026
Half the Genome, Half the Story? Paternal Metabolic Health and Offspring Outcomes in the Era of Modern Obesity PharmacotherapyTheocharis Koufakis, Vasileios Tsimihodimos, Djordje S Popovic
Diabetes/Metabolism Research and Reviews|October 9, 2021
The new dual gastric inhibitory peptide/glucagon-like peptide 1 agonist tirzepatide in type 2 diabetes: Is the future bright?Stella Papachristou, Djordje S Popovic, Nikolaos Papanas
Endocrine|December 29, 2025
From insulin deficiency to insulin resistance: rethinking liver health in type 1 diabetesDjordje S Popovic, Theocharis Koufakis, Georgios Germanidis
Current Vascular Pharmacology|August 17, 2023
The Recent Trends in All-cause and Cardiovascular Mortality among People with Type 1 Diabetes Mellitus - Success is Still Far Away, and We Must Do Better!Djordje S Popovic, Theocharis Koufakis, Nikolaos Papanas
Current Vascular Pharmacology|July 2, 2025
Glucagon-like Peptide-1 Receptor Agonists: Additional Improvement of Erectile Dysfunction in Type 2 DiabetesDjordje S Popovic, Stella Papachristou, Nikolaos Papanas
Advances in Therapy|March 28, 2022
Reduced Progression of Monoclonal Gammopathy of Undetermined Significance to Multiple Myeloma in Type 2 Diabetes Mellitus: Will Metformin Never Stop Its Pleasant Surprises?Stella Papachristou, Djordje S Popovic, Nikolaos Papanas
Journal of Diabetes Science and Technology|May 13, 2025
"Experience Is Simply the Name We Give to Our Mistakes": A New Opportunity to Improve Outcomes in Type 2 DiabetesTheocharis Koufakis, Djordje S Popovic, Giuseppe Maltese
Journal of Magnetic Resonance (San Diego, Calif. : 1997)|August 1, 2017
14GHz longitudinally detected electron spin resonance using microHall sensorsM Bouterfas, S Mouaziz, R S Popovic
Pageof 31

Showing results (21-30 of 303) with videos related to

Sort By:
Pageof 31
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|November 11, 2023
Potential New Therapeutic Implications of Semaglutide: New Colours of the Rainbow?Evanthia Gouveri, Djordje S Popovic, Nikolaos Papanas
Diabetes Research and Clinical Practice|February 19, 2026
Combination therapy for kidney protection in type 1 diabetes mellitus: quo vadis?Djordje S Popovic, Dimitrios Patoulias, Theocharis Koufakis
Diabetes & Metabolism|February 26, 2026
Half the Genome, Half the Story? Paternal Metabolic Health and Offspring Outcomes in the Era of Modern Obesity PharmacotherapyTheocharis Koufakis, Vasileios Tsimihodimos, Djordje S Popovic
Diabetes/Metabolism Research and Reviews|October 9, 2021
The new dual gastric inhibitory peptide/glucagon-like peptide 1 agonist tirzepatide in type 2 diabetes: Is the future bright?Stella Papachristou, Djordje S Popovic, Nikolaos Papanas
Endocrine|December 29, 2025
From insulin deficiency to insulin resistance: rethinking liver health in type 1 diabetesDjordje S Popovic, Theocharis Koufakis, Georgios Germanidis
Current Vascular Pharmacology|August 17, 2023
The Recent Trends in All-cause and Cardiovascular Mortality among People with Type 1 Diabetes Mellitus - Success is Still Far Away, and We Must Do Better!Djordje S Popovic, Theocharis Koufakis, Nikolaos Papanas
Current Vascular Pharmacology|July 2, 2025
Glucagon-like Peptide-1 Receptor Agonists: Additional Improvement of Erectile Dysfunction in Type 2 DiabetesDjordje S Popovic, Stella Papachristou, Nikolaos Papanas
Advances in Therapy|March 28, 2022
Reduced Progression of Monoclonal Gammopathy of Undetermined Significance to Multiple Myeloma in Type 2 Diabetes Mellitus: Will Metformin Never Stop Its Pleasant Surprises?Stella Papachristou, Djordje S Popovic, Nikolaos Papanas
Journal of Diabetes Science and Technology|May 13, 2025
"Experience Is Simply the Name We Give to Our Mistakes": A New Opportunity to Improve Outcomes in Type 2 DiabetesTheocharis Koufakis, Djordje S Popovic, Giuseppe Maltese
Journal of Magnetic Resonance (San Diego, Calif. : 1997)|August 1, 2017
14GHz longitudinally detected electron spin resonance using microHall sensorsM Bouterfas, S Mouaziz, R S Popovic
Pageof 31